The epidemiology of Guillain-Barré syndrome worldwide: A systematic literature review

Neuroepidemiology

Volumn 32, Issue 2, 2009, Pages 150-163

  McGrogan, Anita ^a   Madle, Gemma C ^b   Seaman, Helen E ^b   De Vries, Corinne S ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Epidemiology; Guillain Barr syndrome; Incidence; Systematic review

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; EMBASE; EUROPE; GASTROINTESTINAL INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; MEDICAL RECORD REVIEW; MEDLINE; NORTH AMERICA; PLASMAPHERESIS; PROSPECTIVE STUDY; RELIABILITY; RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMATIC REVIEW;

GUILLAIN-BARRE SYNDROME; HUMANS; POPULATION SURVEILLANCE; RISK FACTORS; WORLD HEALTH;

EID: 57649100604     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184748     Document Type: Review

References (74)

1. Hughes RA, Rees JH: Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis 1997;176:92-98.
2. Asbury AK, Arnason BG, Karp HR, McFarlin DE: Criteria for diagnosis of Guillain-Barre syndrome. Ann Neurol 1978;3:565-566.
3. Govoni V, Granieri E: Epidemiology of the Guillain-Barre syndrome. Curr Opin Neurol 2001;14:605-613.
4. Hughes RAC, Rees JH: Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis 1997;176(suppl 2):S92-S98.
5. Hughes RA, Cornblath DR: Guillain-Barre syndrome. Lancet 2005;366:1653-1666.
6. Tsai CP, Wang KC, Liu CY, Sheng WY, Lee TC: Pharmacoeconomics of therapy for Guillain-Barre syndrome: plasma exchange and intravenous immunoglobulin. J Clin Neurosci 2007;14:625-629.
7. Sladky JT: Guillain-Barre syndrome in children. J Child Neurol 2004;19:191-200.
8. Rantala H, Uhari M, Niemela M: Occurrence, clinical manifestation and prognosis of Guillain-Barre syndrome. Arch Dis Child 1991;66:706-708.
9. van Koningsveld R, Rico R, Gerstenbluth I, Schmitz PI, Ang CW, Merkies IS, et al: Gastroenteritis-associated Guillain-Barre syndrome on the Caribbean island Curacao. Neurology 2001;56:1467-1472.
10. Kinnunen E, Junttila O, Haukka J, Hovi T: Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barre Syndrome. Am J Epidemiol 1998;147:69-73.
11. Govoni V, Granieri E, Manconi M, Capone J, Casetta I: Is there a decrease in Guillain-Barre syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. J Neurol Sci 2003;216:99-103.
12. Cheng Q, Wang DS, Jiang GX, Han H, Zhang Y, Wang WZ, et al: Distinct pattern of age-specific incidence of Guillain-Barre syndrome in Harbin, China. J Neurol 2002;249:25-32.
13. Zhang Y, Wang DS, Han H, Li F, Sheng L, Link H: Epidemiological survey of the incidence of Guillain-Barre syndrome in Harbin from 1997 to 1999. Chin J Clin Rehab 2004;7812-7815.
14. Hui AC, Chow KM, Tang AS, Fu M, Kay R, Wong KS: Electrophysiological, clinical and epidemiological study of Guillain-Barre Syndrome in Hong Kong Chinese. J Clin Neurosci 2005;12:134-136.
15. Rocha MS, Brucki SM, Carvalho AA, Lima UW: Epidemiologic features of Guillain-Barre syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatr 2004;62:33-37.
16. Storey E, Cook M, Peppard R, Newton-John H, Byrne E: Guillain-Barre syndrome and related conditions in Victorian teaching hospitals 1980-1984. Aust NZ J Med 1989;19:687-693.
17. Hankey JG: Guillain-Barre syndrome in Western Australia, 1980-1985. Med J Aust 1987;146:130-133.
18. Kusumi M, Nakashima K, Nakayama H, Takahashi K: Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan. Psychiatry Clin Neurosci 1995;49:169-174.
19. Radhakrishnan K, El-Mangoush MA, Rerryo SE: Descriptive epidemiology of selected neuromuscular disorders in Benghazi, Libya. Acta Neurol Scand 1987;75:95-100.
20. Arami MA, Yazdchi M, Khandaghi R: Epidemiology and characteristics of Guillain-Barre syndrome in the northwest of Iran. Ann Saudi Med 2006;26:22-27.
21. Howlett WP, Vedeler CA, Nyland H, Aarli JA: Guillain-Barre syndrome in northern Tanzania: a comparison of epidemiologic and clinical findings with western Norway. Acta Neurol Scand 1996;93:44-49.
22. Hughes RA, Charlton J, Latinovic R, Gulliford MC: No association between immunization and Guillain-Barre syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 2006;166:1301-1304.
23. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD: The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-676.
24. Rees JH, Thompson RD, Smeeton NC, Hughes RAC: Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 1998;64:74-77.
25. Markoula S, Giannopoulos S, Sarmas I, Tzavidi S, Kyritsis AP, Lagos G: Guillain-Barre syndrome in northwest Greece. Acta Neurol Scand 2007;115:167-173.
26. Chroni E, Papapetropoulos S, Gioldasis G, Ellul J, Diamadopoulos N, Papapetropoulos T: Guillain-Barre syndrome in Greece: seasonality and other clinico-epidemiological features. Eur J Neurol 2004;11:383-388.
27. Guillain-Barre syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. J Neurol Neurosurg Psychiatry 1998;65:218-224.
28. Paolino Z, Govoni V, Tola MR, Casetta I, Granieri E: Incidence of the Guillain-Barre syndrome in Ferrara, Northern Italy, 1981-1987. Neuroepidemiology 1991;10:105-111.
29. Govoni V, Granieri E, Tola MR, Casetta I, Ruppi P, Vaghi L: The frequency of clinical variants of Guillain-Barre syndrome in Ferrara, Italy. J Neurol 1999;246:1010-1014.
30. Beghi E, Bogliun G: The Guillain-Barre syndrome (GBS): implementation of a register of the disease on a nationwide basis. Ital J Neurol Sci 1996;17:355-361.
31. Bogliun G, Beghi E, Italian GBS Registry Study Group: Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand 2004;110:100-106.
32. Chio A, Cocito D, Leone M, Giordana MT, Mora G, Mutani R, et al: Guillain-Barre syndrome: a prospective, population-based incidence and outcome survey. Neurology 2003;60:1146-1150.
33. van Koningsveld R, van Doorn PA, Schmitz PI, Ang CW, van der Meche FG: Mild forms of Guillain-Barre syndrome in an epidemiologic survey in The Netherlands. Neurology 2000;54:620-625.
34. Sridharan GV, Tallis RC, Gautam PC: Guillain-Barre syndrome in the elderly: a retrospective comparative study. Gerontology 1993;39:170-175.
35. Cuadrado JI, Pedro-Cuesta J, Ara JR, Cemillan CA, Diaz M, Duarte J, et al: Guillain-Barre syndrome in Spain, 1985-1997: epidemiological and public health views. Eur Neurol 2001;46:83-91.
36. Cuadrado JI, Pedro-Cuesta J, Ara JR, Cemillan CA, Diaz M, Duarte J, et al: Public health surveillance and incidence of adulthood Guillain-Barre syndrome in Spain, 1998-1999: the view from a sentinel network of neurologists. Neurol Sci 2004;25:57-65.
37. Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J: Epidemiological features of Guillain-Barre syndrome in Sweden 1978-1993. J Neurol Neurosurg Psychiatry 1997;62:447-453.
38. Cheng Q, Jiang GX, Fredrikson S, Link H, Pedro-Cuesta J: Incidence of Guillain-Barre syndrome in Sweden 1996. Eur J Neurol 2000;7:11-16.
39. Hauck LJ, White C, Feasby TE, Zochodne DW, Svenson LW, Hill MD: Incidence of Guillain-Barre syndrome in Alberta, Canada: an administrative data study. J Neurol Neurosurg Psychiatry 2008;79:318-320.
40. McLean M, Duclos P, Jacob P, Humphreys P: Incidence of Guillain-Barre syndrome in Ontario and Quebec, 1983-1989, using hospital services databases. Epidemiology 1994;5:443-448.
41. Church Potter R, Kaneene JB: A descriptive study of Guillain-Barre syndrome in high and low Campylobacter jejuni incidence regions of Michigan: 1992-1999. Neuroepidemiology 2003;22:245-248.
42. Hoppock KC, Greer GG, Walling AD: The incidence of Guillain-Barre syndrome in a metropolitan county, 1984-1988. Kans Med 1994;95:45-47.
43. Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL: The use of hospital discharge data for public health surveillance of Guillain-Barre syndrome. Ann Neurol 1991;30:618-621.
44. Lehmann HC, Köne A, Meyer zu Höste G, Kieseier BC: Incidence of Guillain-Barre syndrome in Germany. J Peripher Nerv Syst 2007;12:285.
45. Alshekhlee A, Hussain Z, Sultan B, Katirji B: Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology 2008;70:1608-1613.
46. Winner SJ, Evans JG: Age specific incidence of Guillain-Barre syndrome in Oxfordshire. Q J Med 1990;77:1297-1304.
47. A prospective study on the incidence and prognosis of Guillain-Barre syndrome in Emilia-Romagna region, Italy (1992-1993). Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. Neurology 1997;48:214-221.
48. Jiang GX, Cheng Q, Ehrnst A, Link H, de Pedro-Cuesta J: Guillain-Barre syndrome in Stockholm county, 1973-1991. Eur J Epidemiol 1997;13:25-32.
49. Jiang GX, de Pedro-Cuesta J, Fredrikson S: Guillain-Barre syndrome in south-west Stockholm, 1973-1991. 1. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand 1995;91:109-117.
50. Sedano MJ, Calleja J, Canga E, Berciano J: Guillain-Barre syndrome in Cantabria, Spain: an epidemiological and clinical study. Acta Neurol Scand 1994;89:287-292.
51. Riggs JE, Cutmann L, Whited JD: Guillain-Barre syndrome: another immune-mediated disease with a predilection for young women? W V Med J 1989;85:382-383.
52. D'Ambrosio G, De Angelis G, Vizoli R: Epidemiology of Guillain-Barre syndrome in Campania (South Italy). Acta Neurol 1983;23:245-252.
53. Barzegar M, Dastgiri S, Karegarmaher MH, Varshochiani A: Epidemiology of childhood Guillan-Barre syndrome in the north west of Iran. BMC Neurology 2007;7:22.
54. Dias-Tosta E, Kuckelhaus CS: Guillain Barre syndrome in a population less than 15 years old in Brazil. Arq Neuropsiquiatr 2002;60:367-373.
55. Congia S, Melis M, Carboni MA: Epidemiologic and clinical features of the Guillain-Barre syndrome in Sardinia in the 1961-1980 period. Acta Neurol 1989;11:15-20.
56. Larson JP, Kvale G, Nyland H: Epidemiology of the Guillain-Barre syndrome in the county of Hordaland, Western Norway. Acta Neurol Scand 1985;71:43-47.
57. Molinero MR, Varon D, Holden KR, Sladky JT, Molina IB, Cleaves F: Epidemiology of childhood Guillain-Barre syndrome as a cause of acute flaccid paralysis in Honduras: 1989-1999. J Child Neurol 2003;18:741-747.
58. Olive JM, Castillo C, Garcia Castro R, de Quadros CA: Epidemiologic study of Guillain-Barre syndrome in children <15 years of age in Latin America. J Infect Dis 1997;175(suppl):S160-S164.
59. Hart DE, Rojas LA, Rosario JA, Recalde H, Roman GC: Childhood Guillain-Barre syndrome in Paraguay, 1990 to 1991. Ann Neurol 1994;36:859-863.
60. Hung KL, Wang HS, Liou WY, Mak SC, Chi CS, Shen EY, et al: Guillain-Barre syndrome in children: a cooperative study in Taiwan. Brain Dev 1994;16:204-208.
61. Artan R: Childhood Guillain Barre syndrome in Antalya, Turkey. Int Med J 1997;4:215-217.
62. Bak P: Guillain-Barre syndrome in a Danish county. Neurology 1985;35:207-211.
63. Halls J, Bredkjaer C, Friis ML: Guillain-Barre syndrome: diagnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol Scand 1988;78:118-122.
64. Haberman S, Benjamin B, Rose FC, Capildeo R: North west Thames registry of neurological disease. J Royal Soc Med 1982;75:443-449.
65. Kaplan JE, Poduska PJ, McIntosh GC, Hopkins RS, Ferguson SW, Schonberger LB: Guillain-Barre syndrome in Larimer County, Colorado: a high incidence area. Neurology 1985;35:581-584.
66. Beghi E, Kurland LT, Mulder DW, Wiederholt WC: Guillain-Barre syndrome: clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol 1985;42:1053-1057.
67. Ismail EA, Shabani IS, Badawi M, Sanaa H, Madi S, Al Tawari A, et al: An epidemiologic, clinical, and therapeutic study of childhood Guillain-Barre syndrome in Kuwait: is it related to the oral polio vaccine? J Child Neurol 1998;13:488-492.
68. Rantala H, Cherry JD, Shields WD, Uhari M: Epidemiology of Guillain-Barre syndrome in children: relationship of oral polio vaccine administration to occurrence. J Pediatr 1994;124:220-223.
69. Rantala H, Uhari M, Niemela M: Occurrence, clinical manifestations, and prognosis of Guillain-Barre syndrome. Arch Dis Child 1991;66:706-708.
70. Farkkila M, Kinnunen E, Weckstrom P: Survey of Guillain-Barre syndrome in southern Finland. Neuroepidemiology 1991;10:236-241.
71. Winer JB: Guillain Barre syndrome. Mol Pathol 2001;54:381-385.
72. Bogliun G, Beghi E, Guillain-Barre Syndrome Registry Study Group: Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barre syndrome. Neurol Sci 2002;23:113-117.
73. Nachamkin I, Allos BM, Ho T: Campylobacter species and Guillain-Barre syndrome. Clin Microbiol Rev 1998;11:555-567.
74. Cheng Q, Jiang GX, Fredrikson S, Link H, Pedro-Cuesta J: Epidemiological surveillance of Guillain-Barre syndrome in Sweden, 1996-1997: network members of the Swedish GBS Epidemiology Study Group. Acta Neurol Scand 2000;101:104-110.